<DOC>
	<DOCNO>NCT02518152</DOCNO>
	<brief_summary>The present study design evaluate combine efficacy Platelet Rich Fibrin ( PRF ) 1 % Alendronate ( ALN ) open flap debridement ( OFD ) treatment intrabony defect chronic periodontitis patient .</brief_summary>
	<brief_title>Platelet Rich Fibrin+1 % Alendronate Treatment Chronic Periodontitis</brief_title>
	<detailed_description>Background : Platelet-rich fibrin ( PRF ) second-generation platelet concentrate , act reservoirs growth factor cytokines key factor regeneration bone maturation soft tissue . Alendronate ( ALN ) , potent member bisphosphonate group know promote tissue regeneration inhibit osteoclastic bone resorption promote osteoblastogenesis . The present study design evaluate combine efficacy PRF 1 % ALN open flap debridement ( OFD ) treatment intrabony defect chronic periodontitis patient . Methods : Ninety patient single defect categorize three group : OFD alone , OFD PRF , OFD PRF+1 % ALN . Clinical parameter ; site specific plaque index ( PI ) , modify sulcus bleed index ( mSBI ) , probe depth ( PD ) , clinical attachment level ( CAL ) gingival marginal level ( GML ) record baseline surgery 9 month post-operatively . Percentage radiographic intra-bony defect depth reduction ( IBD ) evaluate baseline 9 month .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Inclusion criterion Presence 3wall IBD ≥3 mm deep ( distance alveolar crest base defect Intraoral Periapical Radiograph [ IOPA ] ) along interproximal probe depth ( PD ) ≥5 mm phase I therapy ( scale root plan [ SRP ] ) asymptomatic teeth . Aggressive Periodontitis patient ; Systemic condition know affect periodontal status ; medication know affect outcome periodontal therapy ; Hematological disorder insufficient platelet count ( &lt; 200,000/mm3 ) ; Pregnancy/lactation ; Smoking tobacco use form Immunocompromised individual . Those unacceptable oral hygiene ( plaque index27 [ PI ] &gt; 1.5 ) reevaluation Phase I therapy . Teeth furcation involvement , nonvital teeth , carious teeth indicate restoration mobility least grade II also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>